Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients — Ioannis P. Trougakos (2021) | RDL Network
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Article 2021 en
Authors
IT
Ioannis P. Trougakos
ET
Evangelos Terpos
CZ
Christina Zirou
Abstract
1 min read
These findings support vaccination efficacy, also suggesting that vaccination likely offers more protection than natural infection.
Efstathios Kastritis, Evangelos Terpos, Zoi Evangelakou, Foteini Theodorakakou, Despina Fotiou, Maria S. Manola, Despoina D. Gianniou, Tina Bagratuni, Nikolaos Kanellias, Magdalini Migkou, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos
Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Mahesh Agarwal, Jenifer Bear, Robert Burns, Xintao Hu, Eleni Korompoki, Duncan Donohue, David Venzon, Meletios A Dimopoulos, George N. Pavlakis, Barbara K. Felber
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou, Ismini Darmani, Amirah Ullah, Jenifer Bear, Santhi Devasundaram, Robert Burns, Ioannis Baltadakis, Stavros Gigantes, Meletios A Dimopoulos, George N. Pavlakis, Evangelos Terpos, Barbara K. Felber
Discussion(0)
No comments yet. Be the first to comment.